Nephrotex Research Group is a clinical research site located in Dallas, Texas, United States 75231-0929.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
Nephrotex Research Group has participated in 9 clinical trials with 6 currently active.
Therapeutic areas: Primary Membranous Nephropathy, Proteinuric Kidney Disease, Kidney Disease.
Sponsors: Biogen, Vertex Pharmaceuticals Incorporated, Palatin Technologies, Inc.
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Nephrotex Research Group has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Nephrotex Research Group has 9 clinical trials on record, with 6 currently active. Their work covers Primary Membranous Nephropathy, Proteinuric Kidney Disease, Kidney Disease.
Yes — Nephrotex Research Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.